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disease can remit spontaneously after stopping the offending agent without
the need for chelating agents or steroid treatment.http://dx.doi.org/10.1016/j.hkjn.2015.09.0270249
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Objective: Studies on biopsy-proven renal disease in the very old (75 years
and older) are limited in Hong Kong. The aim of this study was to examine
the spectrum of renal diseases and their clinical presentations in the very
old undergoing percutaneous native renal biopsy.
Methods: All native renal biopsies (n Z 43) performed in patients aged 75
years and older by Nephrologists of the United Christian Hospital, Hong
Kong from January 2004 to December 2014 were retrospective analyzed.
Results: A total of 700 percutaneous native renal biopsies were performed.
43 percutaneous native renal biopsies (6.14% of total native renal biopsies)
were done in patients 75 years and older, including 25 males and 18 females.
Primary glomerular diseases (60.47%) occurred more frequently than second-
ary glomerular diseases (39.53%). For primary glomerular diseases, idio-
pathic membranous nephropathy (11.63%) and minimal change disease
(11.63%) were the most frequent diagnosis, followed by IgA nephropathy
(9.30%) and focal segmental glomerulosclerosis (9.30%). For secondary
glomerular diseases, amyloidosis (9.30%) and secondary membranous ne-
phropathy (9.30%) were the most frequent diagnosis followed by hyperten-
sive arterionephrosclerosis (6.98%) and drug induced acute interstitial
nephritis (4.65%). The causes of amyloidosis were multiple myeloma (75%)
and rheumatoid arthritis (25%). Secondary causes of membranous nephropa-
thy are malignancy (75%) and chronic infection (25%). The clinical presenta-
tions were nephrotic syndrome in 51.16% of patients, asymptomatic urinary
abnormalities in 25.58%, acute kidney injury in 18.60%, and acute nephritic
syndrome in 4.65%.
Conclusion: This study is the first renal biopsy series to analyze patients aged
75 years and older in Hong Kong, and the results obtained from this study pro-
vide updated information in the very old with renal disease. Nephrotic syn-
drome is the main indication for renal biopsy. Amyloidosis and secondary
membranous nephropathy are the most frequent histological diagnosis of sec-
ondary glomerular diseases.http://dx.doi.org/10.1016/j.hkjn.2015.09.0280253
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Objective: M-type phospholipase A2 receptor (PLA2R) has been shown as a
target autoantigen in idiopathic membranous nephropathy (IMN) adults.
The correlation between genetic polymorphisms of PLA2R1 and the suscep-
tibility to IMN as well as anti-PLA2R autoantibodies in the Chinese Han pop-
ulation is still unknown. This study aimed to investigate whether single
nucleotide polymorphisms (SNPs) of PLA2R1 correlated with the develop-
ment of IMN in the Chinese Han population.
Methods: One hundred and sixty-five patients with IMN, 59 patients with sec-
ondary membranous nephropathy (SMN) and 241 healthy individuals were
enrolled. SNP rs35771982 of PLA2R1 was genotyped using polymerase chain
reaction-restriction fragment length polymorphism (PCR-RFLP). Thecorrelation between PLA2R1 SNP and clinical parameters of IMN as well as
the presence of anti-PLA2R autoantibodies were analyzed.
Results: The genotype and allele distributions at SNP rs35771982 in PLA2R1
were significantly different among three groups (P < 0.001). The frequency
of CC genotype at rs35771982 was higher in IMN patients than in healthy con-
trols and SMN patients (P < 0.001 and PZ 0.001, respectively) and increased
the risk for IMN (odds ratio Z 0.43, 95% confidence interval Z 0.28e0.65).
IMN patients with CC genotype showed higher positive rate of anti-PLA2R au-
toantibodies than those with CG or GG genotype (PZ 0.003). No influence of
SNP rs35771982 on disease remission was revealed.
Conclusion: SNP rs35771982 of PLA2R1 may contribute to the development
of IMN and correlate with anti-PLA2R autoantibodies, thus playing an impor-
tant role in the pathogenesis of IMN.http://dx.doi.org/10.1016/j.hkjn.2015.09.0290256
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Background: Drug reaction with eosinophilia and systemic symptom (DRESS)
is a rare and life-threatening adverse drug-induced reaction. Allopurinol may
induce severe DRESS syndrome.
Case Summary:We report a successfully treated case of a 41-year-oldmanwith
allopurinol-induced severe DRESS syndrome. The patient was hospitalized for
acute rash, high fever (> 38C) and liver and renal involvement, andwas consid-
ered as DRESS syndrome according to the RegiSCAR inclusion criteria. The pa-
tient further was scored as 6 with the RegiSCAR scoring system for high fever
(score 0), atypical lymphocytes (score 1), skin involvement (> 50% body surface
area, score 1; classic skin rash suggesting DRESS, score 1), liver involvement
(score 1), renal involvement (score 1), resolution more than 15 days (score 0),
and evaluation of other potential causes (negative results of antinuclear anti-
body, blood culture, serology for HAV/HBV/HCV and chlamydia/mycoplasma,
score 1), and he met seven of ten items according to Japanese criteria, which
both indicated the definite diagnosis of DRESS syndrome. His renal function
was impaired severely, and the renal histopathological manifestation was gran-
ulomatous interstitial nephritis (Figure 1). The patient improved significantly
with corticosteroid treatment and hemodialysis (Table 1). During the 1-year
follow-up, the patient relapsed once due to sudden cessation of steroids, but
clinical remission was achieved after readministration of steroids.
Conclusion: Timely intensive treatment may improve the prognosis of pa-
tients with allopurinol-induced severe DRESS syndrome. Gradual withdrawal
of steroids after clinical remission is necessary.Figure 1. Kidney biopsy showed granulomatous interstitial nephritis (hema-
toxylin & eosin, 200).
Table 1. Major laboratory parameters of the index patient.
Day 1 Day 11 Day 35
White blood count ( 109) 27.95 10.77 10.13
Differential leucocyte
count (%)
N78.1, L20.8,
M0.2, E0.4
N78.7, LI6.5,
M4.4, E0
N70.6, L21.5,
M6.7, E1.1
Hemoglobin (g/L) 98 92 85
Platelet ( 109) 258 163 154
Bilirubin (mmol/L) 17.7 6.8 6.6
Bilirubin(conjugated)
(mmol/L)
6.1 4 3.9
Protein (g/L) 54.6 46.5 57.3
Albumin (g/L) 28 25.4 28.6
Aspartate
aminotransferase (U/L)
77 13 16
Alanine
aminotransferase (U/L)
378 31 31
Alkaline phosphatase (U/L) 261 83 62
Gamma-glutamyl
transpeptidase (U/L)
129 62 43
Serum urea (mmol/L) 42.8 26.9 17.16
Serum creatinine (mmol/L) 1336 551 387
Urinary protein
excretion (g/d)
1.511 1.299 1.009
Red blood cells per
high-power field
1.27 1.65 282
White blood cells per
high-power field
15.69 6.75 3.25
Epithelial cells per
high-power field
17.82 1.05 0.53
Specific gravity of urine 1.010 1.012 1.006
Urinary osmotic pressure
(mOsm/kg H2O)
409 483 261
N, neutrophil; L, lymphocyte; E, eosinophil; M, monocyte.
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(n Z 23).
Age, years 73.1 5.1
Gender, male / female 8 / 15
Body weight, kg 63.1 12.3
Hypertension, n (%) 17 (77.3%)
Diabetes mellitus, n (%) 2 (8.7%)
Charlson’s Comorbidity Index score 4.6 1.7
Diagnosis, n (%)
Minimal change nephropathy 4 (17.4%)
Primary focal segmental glomerulosclerosis 3 (13.0%)
IgA nephropathy 1 (4.3%)
Lupus nephritis 2 (8.7%)
Crescentic glomerulonephritis 5 (21.7%)
Post-infectious glomerulonephritis 1 (4.3%)
Membranous nephropathy 7 (30.4%)
Immunosuppressant, n (%)
Steroid 23 (100%)
Cyclosporin 7 (30.4%)
Mycophenolate mofetil 2 (8.7%)
Cyclophosphamide 4 (17.4%)0275
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Objective: To assess the changing prevalence of idiopathic membranous ne-
phropathy (iMN) in Chinese patients undergoing renal biopsy from our
nephrology center.
Methods: The records of 8559 consecutive native renal biopsies performed in
adults (14 years of age) in the First Affiliated Hospital of Zhejiang Univer-
sity between 2005 and 2014 were retrospectively analysed. The criteria for
renal biopsy and pathologic diagnosis were kept unchanged. The patients
were grouped according to a 5-year interval, 2005e2010 (period 1),
2010e2014 (period 2), and divided into four age groups (14e24, 25e44,
45e59,  60 years old).
Results: Among 8559 specimens, 6336 (74.03%) were diagnosed as primary
glomerular diseases (PGD). IgA nephropathy (IgAN) was the most common
PGD (55.67%), with a significant decrease in the period 2 (50.82% vs.
64.79%, P < 0.001). The prevalence of iMN in PGD increased rapidly
from 16.59% in period 1 to 25.21% in period 2 in all groups of age (P <
0.001). In patients aged 45e59 years, the proportion of renal histopathol-
ogy stage I and stage II of iMN in PGD was significantly higher in period 2
than in period 1 (20.54% vs. 30.29%, P < 0.001). 51.08% of petients with
iMN presented with nephrotic syndrome, the remainder presented with
chronic nephritis syndrome (28.11%) and asymptomatic urinary abnormal-
ity (20.81%). There were no significant differences in clinical characteris-
tics including age, gender, hypertension, serum cholesterol, serum
albumin and glomerular filtration rate between the two periods (P >
0.05).Conclusion: The prevalence of iMN in PGD in our nephrology center has
increased significantly over the past 10 years. The increase of adult iMN is
mainly due to the increase in the early stages of iMN in middle-aged patients.http://dx.doi.org/10.1016/j.hkjn.2015.09.0310278
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Objective: Glomerulonephritis is not uncommon among elderly and immuno-
suppressive treatment is often needed to achieve remission. Compared to
young patients, elderly might bear higher complication risks especially infec-
tion. We looked into the adverse events among elderly who received immu-
nosuppressive therapy.
Methods: We retrospectively reviewed all elderly (age 65 years) who under-
went renal biopsy at our institution between 2007 and 2014. Patients diagnosed
to have glomerulonephritis were included. Their baseline demographics, diag-
nosis, immunosuppressants received, details of infection-related hospitaliza-
tion, other clinical outcomes including treatment response, development
into end-stage renal disease (ESRD) or death were retrieved.
Results: 27 patients were identified and 23 of them had received immuno-
suppressants. Their total follow-up duration was 764.4 patient-months,
which included 450.8 patient-months of immunosuppressive treatment.
Baseline demographics, treatment details, infectious complications and
other clinical outcomes of the cohort are shown in Table 1. During follow-
up, there were 60 hospitalizations, among which 25 episodes (41.7%) were
due to infections involving 12 patients (51.2%). Overall infection-related hos-
pitalization rate was once every 30.6 patient-months (i.e. 0.39 episodes per
year). Among the 12 patients, median onset of infection was 3.2 months (IQR
1.6e45.3) after starting immunosuppressants. Eventually, 4 patients (17.4%)
progressed to ESRD and 5 patients (21.7%) died. 60% mortality was attributed
to infections. Comparing patients with and without infections, patients
complicated with infections had lower body weight, higher baseline serum
creatinine and more non-responders to treatment (Table 2). Binary logistic
regression confirmed non-responder (OR 10.5, 95% CI 1.4e81.1, p Z 0.02)
as the only independent risk factor for infectious complications.
Conclusion: Immunosuppressive treatment is associated with infectious
complication risks among elderly suffering from glomerulonephritis. Patients
with poor clinical response are particularly prone to developing infections.
Over-aggressive treatment should be avoided in this high-risk group in order
to minimize infection risks and mortality.
